Skip to main content

Effectiveness and cost-effectiveness of the modified Pilates method versus aerobic exercise in the treatment of patients with fibromyalgia: protocol for a randomized controlled trial



Fibromyalgia is characterized by chronic generalized pain, fatigue, sleep disorders and other symptoms. Physical exercise is recommended as the first choice of non-pharmacological therapy. Thus, the aim of this study is to evaluate the effectiveness and cost-effectiveness of modified Pilates exercises compared to aerobic exercises in the treatment of patients with fibromyalgia.


In this randomized controlled trial with blinded assessor, 98 patients who meet the fibromyalgia classification criteria of the American College of Rheumatology 2010, aged between 20 and 75 years, and with pain intensity greater than or equal to 3 points in the Pain Numerical Rating Scale, will be randomly divided into Aerobic Group (aerobic exercises on treadmills or stationary bikes) and Pilates Group (modified Pilates exercises), and treated twice a week for eight weeks on the Center for Excellence in Clinical Research in Physical Therapy at Universidade Cidade de São Paulo, Brazil. The following outcomes will be evaluated by a blinded assessor at baseline, eight weeks, six months, and 12 months after randomization: impact of fibromyalgia assessed by the Fibromyalgia Impact Questionnaire, pain intensity by the Pain Numerical Rating Scale, kinesiophobia by the Tampa Scale of Kinesiophobia, specific disability by the Patient-Specific Functional Scale, functional capacity by the 6-min Walk Test, quality of sleep by the Pittsburgh Sleep Quality Index, and health-related quality of life by EQ-5D-3L and SF-6D questionnaires.


It is expected that the Pilates exercises will be more effective than aerobic exercises in improving clinical outcomes and that this improvement will be maintained over the medium to long term. This study aims to clarify whether the Pilates method can be incorporated into the clinical practice of physical therapists treating patients with fibromyalgia. The study will also provide information on which exercise will be most cost-effective, information that can be used by insurers and public health systems.

Trial registration

This study was prospectively registered at the Clinical Trials Registry (NCT03050606) in February 2017.

Peer Review reports


Fibromyalgia is a rheumatologic disease characterized by chronic generalized pain, hyperalgesia, and allodynia [1]. It is also characterized by the presence of symptoms such as fatigue, sleep disorders, morning stiffness, headache, and paresthesia [1]. It can be classified clinically, following the diagnostic criteria of the American College of Rheumatology 2010 [2]: 1) Widespread Pain Index (WPI), calculated by adding up the number of areas in which the patient reported pain in the last week; and 2) Severity of Symptoms (SS), calculated by adding up the severity of fatigue, waking unrefreshed, cognitive symptoms and somatic symptoms [2]. To be classified as having fibromyalgia, a patient must present the following three clinical conditions: WPI ≥ 7 and SS ≥ 5 or WPI between 3 and 6 and SS ≥ 9 points; presence of symptoms at the same intensity for at least three months; and no disease/condition that could be the cause of the pain [2]. One of the main pathophysiological mechanisms of fibromyalgia is central sensitization, defined as increased responsiveness of nociceptive neurons in the central nervous system to their normal or subthreshold afferent input [3]. In this case, pain can arise spontaneously or be elicited by a normally innocuous stimuli (allodynia), is exaggerated and prolonged in response to a noxious stimuli (hyperalgesia), and spreads beyond the site of injury (secondary hyperalgesia) [4].

The average global prevalence of fibromyalgia is 2.7%, with a higher incidence in women (3:1) [5, 6]. In Brazil, this prevalence is 4.4% in the population aged 35–60 years [7] and 5.5% in people over 65 years of age [8]. Economic impact studies show that patients with fibromyalgia are significant consumers of health services and generate significant costs related to loss of productivity [9]. The average annual cost of fibromyalgia is estimated at approximately 6000 Canadian dollars [10], approximately 2,827,000 Yen of indirect cost and 1,943,000 Yen of direct cost in Japan [11], and this cost is even higher in European patients, approximately 8000 to 13,000 Euros per year [12, 13].

The current recommendation for the treatment of fibromyalgia includes non-pharmacological and self-management strategies combined with pharmacological therapies [14]. Exercise is the first choice of treatment, with stronger evidence for supervised aerobic exercise. However, there is also evidence recommending muscle strengthening and stretching exercises [5, 14, 15]. Some studies [15,16,17] demonstrate that aerobic exercise improves fibromyalgia symptoms when compared to control groups or other interventions (such as education and cognitive-behavioral therapy). However, the size of these effects is small to moderate [16, 17]. Another type of exercise that can be a good option for the treatment of these patients is the modified Pilates method, as it has exercises to mobilize, stretch, and strengthen muscles. The modified Pilates is currently the most widely used approach by physical therapists, is tailored to the practitioner, divided into levels of progression, and emphasizes the normal curvatures of the spine during the exercises [18]. Pilates exercises are often indicated for the treatment of low back pain [19, 20], but there are only four pilot studies on the effects of the Pilates method in patients with fibromyalgia [21,22,23,24]. These studies demonstrate that Pilates may be better than short-term exercise at home [21] and connective tissue massage for pain-pressure threshold and anxiety [22], but similar to yoga exercises [24] and a control group without intervention [23] in patients with fibromyalgia.

A systematic review [25] showed that there is substantial evidence that various modalities of exercise improve pain and function in patients with fibromyalgia but also detected inconclusive evidence for new modalities such as Pilates, yoga and tai chi because of the lack of studies and methodological flaws of the existing studies. This demonstrates the need for studies with adequate comparator groups and samples to verify the actual effectiveness of modified Pilates exercises in this disease. In addition, fibromyalgia generates high costs in health, but there is little information about the cost-effectiveness of the treatments indicated for its control, and it is extremely important to identify the most effective and less costly treatments. Thus, the aim of this study is to evaluate the effectiveness and cost-effectiveness of modified Pilates exercises compared to aerobic exercises in the treatment of patients with fibromyalgia.


Study design

This study is a randomized controlled trial with parallel group and blinded assessor.

Study settings

Participants will be treated at the Center for Excellence in Clinical Research in Physical Therapy at Universidade Cidade de São Paulo in Sao Paulo, SP, Brazil. This project was approved by the Research Ethics Committee of Universidade Cidade de São Paulo (CAAE: 51328215.1.0000.0064). It was also prospectively registered on Clinical Trials Registry (NCT03050606) and received funding from the Sao Paulo Research Foundation - FAPESP (process number 2016/12962–0 and 2015/21590–6). If there is a need to change the protocol, the changes will be immediately reported to the Research Ethics Committee and carried out at the registration site before the first patient is admitted to the study. The flow of participants through the study will follow the recommendations of the Consolidated Standards of Reporting Trials Statement and is outlined in Fig. 1.

Fig. 1

Study design

Sample size calculation

The study was designed to detect a clinically significant 8 points (14%) difference in the impact of fibromyalgia assessed by the Fibromyalgia Impact Questionnaire eight weeks after randomization (estimated standard deviation = 12), assuming α = 0.05, statistical power of 80%, and loss to follow-up of 15%. This value represents the minimal clinically important difference [26]. The sample size calculation resulted in a sample of 98 participants divided into two groups of 49 each. To reach this number, the study will be promoted in community newspapers and on the internet.

Eligibility criteria

The study will include patients of both genders who meet the fibromyalgia classification criteria of the American College of Rheumatology 2010 [2], aged between 20 and 75 years, and with pain intensity greater than or equal to 3 points in the Pain Numerical Rating Scale [27]. The exclusion criteria will be contraindications to physical exercise [28], pregnancy, uncontrolled systemic diseases (diabetes mellitus, systemic arterial hypertension, and thyroid dysfunctions), neurological, cardiorespiratory, and musculoskeletal conditions that interfere in the treatment, e.g., paralysis, significant loss of sensitivity (such as diabetic foot), changes in level of consciousness and understanding, advanced joint diseases, injury or severe pain in the lower limbs that limit the performance of aerobic exercises (such as severe arthrosis, hip or knee arthroplasty, severe rheumatoid arthritis, cervicalgia with irradiation to the upper limbs, meniscus injury, plantar fasciitis, partial or total muscle tears, amputations, among others), recent surgery, and inability to understand or speak Portuguese. Prior screening will be conducted by telephone by a previously trained student, with exception of irradiated pain, which will be assessed in a face-to-face assessment. Participants will be asked to not look for other treatment (whether based on exercises or non-pharmacological interventions) while undertaking the study intervention.

Assessment of clinical outcomes

Before baseline assessment, the participants will give consent and sign the Informed Consent Form. A blinded assessor will confirm the eligibility criteria and the diagnosis of fibromyalgia through the criteria of the American College of Rheumatology 2010 [2]. Next, demographic and anthropometric data will be collected, as well as information on the use of medications (type and quantity) for fibromyalgia and physical therapy or other previous treatment. Finally, the participants will be assessed for the primary and secondary outcomes. The assessments will be performed at baseline, eight weeks, six months, and 12 months after randomization, and in the last three assessments, the patients will be instructed not to provide information about their treatment to the blinded assessor. In the follow-ups assessments, patients will also be asked about the use of medication and physical activity or other treatment for fibromyalgia. The baseline and eight-week assessments will be face-to-face, and the six- and twelve-month assessments will be conducted over the phone to minimize loss to follow-up. In the eight-week assessment patients will also be asked about their satisfaction with the treatment. All of the scales and the questionnaire used in this study have already been translated and adapted to Brazilian Portuguese [29,30,31,32,33,34,35,36,37,38,39,40,41].

The primary outcome is the impact of fibromyalgia eight weeks after randomization. The secondary outcomes are: impact of fibromyalgia six and 12 months after randomization; pain intensity, kinesiophobia, sleep quality, health-related quality of life and specific disability eight weeks, six months, and 12 months after randomization; pain intensity at each session, before and after treatment; and functional capacity eight weeks after randomization (Table 1).

Table 1 Description of the outcome measures

Economic assessment

Cost-effectiveness and cost-utility analysis will be carried out to evaluate the incremental cost per life-years adjusted for the quality (QALYs) of the interventions. The Fibromyalgia Impact Questionnaire will be used for cost-effectiveness analysis, and the EQ-5D-3L and SF-6D questionnaires will be used for cost-utility analysis. The costs measured in this study using resources by the participants will be: direct costs, which correspond to the costs of this participant to the public and private healthcare systems and the participant’s out-of-pocket expenses; and indirect costs through loss of productivity due to fibromyalgia. This assessment will be performed by information from a cost diary that the participants will keep at home. Three, six, nine, and 12 months after randomization, the assessor will collect these data by telephone. Thus, the costs of the interventions and the participants’ own expenses will be identified, measured, and validated. Table 2 shows the types of resources evaluated and the data sources from which the proposed information and evaluation methods will be taken. The number of work absences will be multiplied by the average salary rate to estimate the costs of paid work leave. Bus and subway fares or the price of fuel will be used to estimate transportation costs. Sensitivity analysis will test uncertainty in key parameters, such as the selection of cost weights and statistical variation in quality of life scores.

Table 2 Assessment of the resource used

Randomization and concealed allocation

The randomization of the study will be performed by a researcher not involved in the recruitment of participants (CMNC), using Microsoft Excel for Windows. Allocation will be concealed and sealed in opaque envelopes in consecutively numbered sequences. Participants will be randomized to either the Aerobic Group or the Pilates Group.


Both groups will receive education through an educational booklet with information on fibromyalgia, central sensitization, self-care strategies for pain management and fatigue reduction (such as graduating activities of daily living and use of self-massage), improved sleep (such as avoiding caffeine and cigarette, and watching TV one hour before bedtime), improved depression and stress management (such as practicing physical activity and performing psychotherapy) [42, 43]. The booklet will also provide information about the importance of exercise in the management of fibromyalgia and delayed onset muscle soreness to reduce fear and avoidance of patients in relation to the practice of exercises. The participants may continue to use the medications prescribed by their doctor. The treatment will be carried out in person for eight weeks, with 16 individually tailored sessions lasting 60 min each. At each session, the participants will rate their pain before and after exercise. Any adverse effects caused by the exercises will be noted daily.

The Aerobic Group will perform aerobic exercises, and the training heart rate (HR) will be 57 to 76% of maximum heart rate (HRmax), which corresponds to the mild to moderate exercise intensity indicated for these patients [16, 25, 44]. HRmax will be calculated indirectly by the equation for maximum predicted heart rate by age (HRmax = 208–0.7 x age) [45, 46]. Patients should maintain training HR, which will be monitored by the frequencymeter, and a perceived effort between 11 and 13 (considered mild to moderate) [47] on the Borg scale [48]. The Borg scale will be the main factor considered when changing the intensity of the exercise if the patient presents a high perceived exertion and still does not reach the training HR. The indirect prescription of HRmax was chosen because it has been validated for sedentary patients with fibromyalgia and because it shows good correlation (r = 0.642; p < 0.05) with the HRmax obtained through ergospirometry [45]. The aerobic exercises will be done on a treadmill (model LX 3.0) or stationary bicycle (models LXU and LXR, Movement Fitness Equipment, Sao Paulo, SP, Brazil). The choice of treadmill or bicycle will be based on the comorbidities and preferences of the participant, because there are no differences between various aerobic exercise modalities in improving clinical outcomes in patients with fibromyalgia [14, 16, 17], and the chosen modality will be maintained until the end of the treatment [16]. The sessions will start with a warm-up (10-min walk) and will end with relaxation (10-min massage with a ball) with the patient lying down. The participants will be informed that they may have a tolerable increase in pain and fatigue in the short term, but these symptoms should return to baseline levels after the first weeks of exercise at adequate intensity [16]. The physical therapists responsible for aerobic exercise (EMESS and GCM) have two and seven years of undergraduate training, specialization in Sports Physical Therapy and Musculoskeletal Physical Therapy, and experience with the prescription of aerobic exercises.

The Pilates Group will receive a specific Pilates exercise program based on a previously published exercise booklet [49] with the inclusion of a few new exercises (Additional file 1). The sessions will include mat exercises with accessories as well as equipment-based exercises (Cadillac, Reformer, Ladder Barrel, and Step Chair, Metalife, Sao José, SC, Brazil). The last 10 min of the session will also consist of relaxation with a ball massage. In the first session, the participants will receive instructions on the method and will be trained on powerhouse activation through isometric contraction of the transverse abdominal, multifidus, and pelvic floor muscles associated with expiration [50, 51]. The exercises of the modified Pilates method will be executed in three levels of difficulty: basic, intermediate, and advanced. This level of difficulty will be defined individually and the participant’s progress between the levels will depend on how well they do the 10 repetitions of the exercises without postural compensations [52, 53]. The physical therapists responsible for Pilates exercises (KFMF and GCM) have six and ten years of undergraduate training, specialization in Musculoskeletal Physical Therapy, and seven and nine years of experience with the Pilates method.

The participants who are allocated to one group will not be transferred to the other group under any circumstances. If the participant is unable to perform the treatment after allocation, he will not do that specific exercise and will be reassessed according to the principles of intention-to-treat analysis. When the participants miss a session, the therapists will contact them by phone to schedule a make-up session. In these cases of absence, the 8-week protocol can be extended for up to 10 weeks to include the make-up sessions. All patients will receive refund for the money spent on public transportation to attend the treatment, which is a strategy to improve adherence in low income countries.

Statistical analysis

All assessment forms will be scanned and stored in a safe place, and data tabulation will be saved on the study’s computer and on pen drives to avoid losses. The participants will be coded by numbers to maintain the confidentiality of their personal data, which will not be disclosed. One of the researchers (CMNC) will certify the data collection stage. The final results of the study will only be revealed upon completion of all follow-ups, and only the authors of the article will have access to the data prior to publication.

The data will be entered twice to avoid tabulation errors, and the statistician will receive the coded data and will be blind to group allocation. In both groups, descriptive analysis and evaluation of data normality will be performed through the visual inspection of histograms. The mean effects of the interventions and the differences between groups for all outcomes will be calculated using linear mixed models, which incorporate terms for the treatment groups, time (follow-ups), and interaction terms (treatment groups versus time). Time will be coded as a categorical variable (i.e., four variables will be created for the category baseline, eight weeks, six months, and 12 months). Treatment coefficients versus time interactions will be equivalent to the estimates of the differences between groups. The statistical analysis will use the software SPSS 19 for Windows.

The cost-effectiveness analysis will be performed using the impact of fibromyalgia as outcome, and the cost-utility analysis using QALYs. Mean between-group cost differences will be calculated for total and disaggregated costs. Seemingly unrelated regression analyses will be performed in which effect and cost differences will be corrected for their baseline values if available, while also taking into account the possible correlation between effects and costs [54]. Incremental cost-effectiveness and cost-utility ratios will be calculated by dividing the corrected difference in total costs by the difference in effects. Uncertainty surrounding the cost differences and incremental cost-effectiveness and cost-utility ratios will be estimated using Bias Corrected and Accelerated bootstrapping techniques (5000 replications). The latter will be graphically presented in cost-effectiveness planes [55]. Cost-effectiveness acceptability curves will be estimated to indicate the intervention’ probability of being cost-effective compared with other at different values of willingness-to-pay [56]. The economic evaluation will be performed using STATA V.14.

In addition, a survival analysis will be performed to evaluate the number of sessions necessary for a 30% pain reduction compared to the initial pain, and this value was chosen because it is considered a minimal clinically significant difference in pain in patients with fibromyalgia [57]. This analysis will be performed using the Kaplan-Meier method [58] and the comparison between the groups by the Log-Rank test [59]. All analyses will follow the intention-to-treat principle. The significance level will be set at 5%. Table 3 shows the timeline of the study.

Table 3 Timeline for the schedule of enrollment, interventions, and assessments


Until the moment, this is the most robust and least biased study about the effectiveness of the Pilates method as a treatment resource for patients with fibromyalgia, comparing it with aerobic exercise. It is also the first study to investigate the cost-effectiveness of two different modalities of therapeutic exercise. Current evidence shows that aerobic exercise does not generate very good adherence in the treatment of patients with fibromyalgia [60], although it has a low to moderate effect on the improvement of their symptoms [16]. Pilates method can lead to greater adherence [61] because it uses equipment and exercises divided into levels of progression. Pilates exercises may cause less muscle soreness and may be more pleasurable and stimulating, which would facilitate its implementation in patients with fibromyalgia who tend to be resistant to exercise. Finally, there is little information on the long-term effects of different exercise modalities for patients with fibromyalgia, and this study will monitor these patients for one year.

This study aims to clarify whether the Pilates method can be incorporated into the clinical practice of physical therapists treating patients with fibromyalgia, as well as which exercises to use and how these exercises can be performed. An easy-to-replicate protocol for aerobic exercise in these patients, with adequate training intensity and frequency, will also be described, as well as information about muscle soreness pain and progression of exercises in each exercise modality. The study will also provide information on which exercise will be most cost-effective, information that can be used by insurers and public health systems. With this study, patients will know whether the Pilates method can be used as an alternative treatment and which exercise modality causes less pain.

The study took all measures to minimize the risks of methodological bias, that is, it was prospectively registered, and it has a relevant sample, concealed allocation, intention-to-treat analysis, and blinded assessor. It allows generalization of the data for the majority of patients with fibromyalgia. In addition, it has pragmatic interventions, with Pilates exercises being performed as in clinical practice, with individualized exercises according to the clinical conditions of the participants each day, without a fixed protocol. The aerobic exercise will be prescribed following the recommendations of the most recent systematic reviews [16, 25] and the American College of Sports Medicine [44], respecting the individuality and clinical condition of each participant by monitoring exercise intensity. The physical therapists responsible for the interventions have clinical experience in the prescription of the respective exercises. The study has as a limitation the non-blinding of participants and therapists, and this limitation stems from the type of intervention (physical exercise).



Euroqol 5 dimensions


Heart rate


Maximum heart rate


Quality adjusted life years


Short-form 6 dimensions


Severity of symptoms


Widespread pain index


  1. 1.

    Carville SF, Arendt-Nielsen L, Bliddal H, Blotman F, Branco JC, Buskila D, et al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis. 2008;67(4):536–41.

    CAS  Article  Google Scholar 

  2. 2.

    Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62(5):600–10.

    Article  Google Scholar 

  3. 3.

    International Association for the Study of Pain (IASP). IASP Terminology Seattle: IASP Press; 2017 [update from 2012] [cited 11 May 2018]. Available from:

  4. 4.

    Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009;10(9):895–926.

    Article  Google Scholar 

  5. 5.

    Busch AJ, Webber SC, Richards RS, Bidonde J, Schachter CL, Schafer LA, et al. Resistance exercise training for fibromyalgia. Cochrane Database Syst Rev. 2013;12:CD010884.

    Google Scholar 

  6. 6.

    Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep. 2013;17(8):356.

    Article  Google Scholar 

  7. 7.

    Assumpcao A, Cavalcante AB, Capela CE, Sauer JF, Chalot SD, Pereira CA, et al. Prevalence of fibromyalgia in a low socioeconomic status population. BMC Musculoskelet Disord. 2009;10:64.

    Article  Google Scholar 

  8. 8.

    Santos AMB, Burti JS, Lopes JB, Scazufca M, Marques AP, Pereira RMR. Prevalence of fibromyalgia and chronic widespread pain in community-dwelling elderly subjects living in São Paulo, Brazil. Maturitas. 2010;67(3):251–5.

  9. 9.

    Annemans L, Wessely S, Spaepen E, Caekelbergh K, Caubere JP, Le Lay K, et al. Health economic consequences related to the diagnosis of fibromyalgia syndrome. Arthritis Rheum. 2008;58(3):895–902.

    CAS  Article  Google Scholar 

  10. 10.

    Robinson RL, Birnbaum HG, Morley MA, Sisitsky T, Greenberg PE, Claxton AJ. Economic cost and epidemiological characteristics of patients with fibromyalgia claims. J Rheumatol. 2003;30(6):1318–25.

    PubMed  Google Scholar 

  11. 11.

    Lee LK, Ebata N, Hlavacek P, DiBonaventura M, Cappelleri JC, Sadosky A. Humanistic and economic burden of fibromyalgia in Japan. J Pain Res. 2016;9:967–78.

    Article  Google Scholar 

  12. 12.

    Boonen A, van den Heuvel R, van Tubergen A, Goossens M, Severens JL, van der Heijde D, et al. Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis. Ann Rheum Dis. 2005;64(3):396–402.

    CAS  Article  Google Scholar 

  13. 13.

    Cabo-Meseguer A, Cerda-Olmedo G, Trillo-Mata JL. Fibromyalgia: prevalence, epidemiologic profiles and economic costs. Med Clin (Barc). 2017;149(10):441–8.

    Article  Google Scholar 

  14. 14.

    Fitzcharles MA, Ste-Marie PA, Goldenberg DL, Pereira JX, Abbey S, Choiniere M, et al. 2012 Canadian guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary. Pain Res Manag. 2013;18(3):119–26.

    Article  Google Scholar 

  15. 15.

    Macfarlane G, Kronisch C, Dean L, Atzeni F, Häuser W, Fluß E, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017;76: 318-28.

  16. 16.

    Häuser W, Klose P, Langhorst J, Moradi B, Steinbach M, Schiltenwolf M, et al. Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta-analysis of randomised controlled trials. Arthritis Res Ther. 2010;12(3):R79.

    Article  Google Scholar 

  17. 17.

    Bidonde J, Busch AJ, Schachter CL, Overend TJ, Kim SY, Góes SM, et al. Aerobic exercise training for adults with fibromyalgia. Cochrane Libr. 2017;6:CD012700.

  18. 18.

    Latey P. The Pilates method: history and philosophy. J Bodyw Mov Ther. 2001;5(4):275–82.

    Article  Google Scholar 

  19. 19.

    Yamato TP, Maher CG, Saragiotto BT, Hancock MJ, Ostelo RW, Cabral CM, et al. Pilates for low back pain. Cochrane Database Syst Rev. 2015;7:CD010265.

    Google Scholar 

  20. 20.

    Wells C, Kolt GS, Marshall P, Hill B, Bialocerkowski A. The effectiveness of Pilates exercise in people with chronic low back pain: a systematic review. PLoS One. 2014;9(7):e100402.

    Article  Google Scholar 

  21. 21.

    Altan L, Korkmaz N, Bingol U, Gunay B. Effect of pilates training on people with fibromyalgia syndrome: a pilot study. Arch Phys Med Rehabil. 2009;90(12):1983–8.

    Article  Google Scholar 

  22. 22.

    Ekici G, Unal E, Akbayrak T, Vardar-Yagli N, Yakut Y, Karabulut E. Effects of active/passive interventions on pain, anxiety, and quality of life in women with fibromyalgia: randomized controlled pilot trial. Women Health. 2017;57(1):88–107.

    Article  Google Scholar 

  23. 23.

    Komatsu M, Avila MA, Colombo MM, Gramani-Say K, Driusso P. Pilates training improves pain and quality of life of women with fibromyalgia syndrome. Rev Dor. 2016;17(4):274–8.

  24. 24.

    Palekar T, Basu S. Comparative study of pilates exercise verses yogasana in the treatment of fibromyalgia syndrome: a pilot study. Int J Pharm Bio Sci. 2014;5(3):410–20.

    Google Scholar 

  25. 25.

    Bidonde J, Busch AJ, Bath B, Milosavljevic S. Exercise for adults with fibromyalgia: an umbrella systematic review with synthesis of best evidence. Curr Rheumatol Rev. 2014;10(1):45–79.

    Article  Google Scholar 

  26. 26.

    Bennett RM, Bushmakin AG, Cappelleri JC, Zlateva G, Sadosky AB. Minimal clinically important difference in the fibromyalgia impact questionnaire. J Rheumatol. 2009;36(6):1304–11.

    Article  Google Scholar 

  27. 27.

    Ostelo RW, de Vet HC. Clinically important outcomes in low back pain. Best Pract Res Clin Rheumatol. 2005;19(4):593–607.

    Article  Google Scholar 

  28. 28.

    Td C, Ad N, Lazzoli JK, Magni JRT, Rezende L, Drummond FA, et al. Posição oficial da Sociedade Brasileira de Medicina do Esporte: atividade física e saúde. Rev Bras Med Esporte. 1996;2(4):79–81.

    Google Scholar 

  29. 29.

    Costa LO, Maher CG, Latimer J, Ferreira PH, Ferreira ML, Pozzi GC, et al. Clinimetric testing of three self-report outcome measures for low back pain patients in Brazil: which one is the best? Spine. 2008;33(22):2459–63.

    Article  Google Scholar 

  30. 30.

    Marques AP, Santos AMB, Assumpção A, Matsutani LA, Lage LV, Pereira CAB. Validation of the Brazilian version of the fibromyalgia impact questionnaire (FIQ). Rev Bras Reumatol. 2006;46(1):24–31.

    Article  Google Scholar 

  31. 31.

    de Souza FS, da Silva MC, Siqueira FB, Maher CG, Costa LOP. Psychometric testing confirms that the Brazilian-Portuguese adaptations, the original versions of the fear-avoidance beliefs questionnaire, and the Tampa scale of Kinesiophobia have similar measurement properties. Spine. 2008;33(9):1028–33.

    Article  Google Scholar 

  32. 32.

    Siqueira FB, Teixeira-Salmela LF, Magalhães LC. Análise das propriedades psicométricas da versão brasileira da Escala Tampa de Cinesiofobia. Acta Ortop Bras. 2007;15(1):6.

    Article  Google Scholar 

  33. 33.

    Campolina AG, Bortoluzzo AB, Ferraz MB, Ciconelli RM. Validity of the SF-6D index in Brazilian patients with rheumatoid arthritis. Clin Exp Rheumatol. 2009;27(2):237–45.

    Google Scholar 

  34. 34.

    Campolina AG, Bortoluzzo AB, Ferraz MB, Ciconelli RM. The SF-6D Brazil: construction models and applications in health economics. Rev Assoc Med Bras. 2010;56(4):409–14.

    Article  Google Scholar 

  35. 35.

    King S, Wessel J, Bhambhani Y, Maikala R, Sholter D, Maksymowych W. Validity and reliability of the 6 minute walk in persons with fibromyalgia. J Rheumatol. 1999;26(10):2233–7.

    CAS  PubMed  Google Scholar 

  36. 36.

    Pankoff BA, Overend TJ, Lucy SD, White KP. Reliability of the six-minute walk test in people with fibromyalgia. Arthritis Care Res. 2000;13(5):291–5.

    CAS  Article  Google Scholar 

  37. 37.

    ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111–7.

    Article  Google Scholar 

  38. 38.

    Bertolazi AN, Fagondes SC, Hoff LS, Dartora EG, Miozzo IC, de Barba ME, et al. Validation of the Brazilian Portuguese version of the Pittsburgh sleep quality index. Sleep Med. 2011;12(1):70–5.

    Article  Google Scholar 

  39. 39.

    Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21(2):271–92.

    Article  Google Scholar 

  40. 40.

    Brazier J, Usherwood T, Harper R, Thomas K. Deriving a preference-based single index from the UK SF-36 health survey. J Clin Epidemiol. 1998;51(11):1115–28.

    CAS  Article  Google Scholar 

  41. 41.

    de Miranda MR, Andrade MV, de Souza Noronha KVM, Kind P. EQ-5D-3L as a health measure of Brazilian adult population. Qual Life Res. 2015;24(11):2761–76.

    Article  Google Scholar 

  42. 42.

    Whaley M, Brubaker P, Otto R, Armstrong L. ACSM’s guidelines for exercise testing and prescription. 7th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2006.

    Google Scholar 

  43. 43.

    Marques A, Yuan S, Matsutani L, Santos A. Avaliação e tratamento da fibromialgia em atletas. PROFISIO Programa de atualização em fisioterapia esportiva e traumato-ortopédica. Ciclo 4 (1). Porto Alegre: Artmed Panamericana; 2014. p. 99–161.

    Google Scholar 

  44. 44.

    Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM, et al. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc. 2011;43(7):1334–59.

    Article  Google Scholar 

  45. 45.

    Lemos MC, Valim V, Zandonade E, Natour J. Intensity level for exercise training in fibromyalgia by using mathematical models. BMC Musculoskelet Disord. 2010;11:54.

    Article  Google Scholar 

  46. 46.

    Tanaka H, Monahan KD, Seals DR. Age-predicted maximal heart rate revisited. J Am Coll Cardiol. 2001;37(1):153–6.

    CAS  Article  Google Scholar 

  47. 47.

    Jones KD, Burckhardt CS, Deodhar AA, Perrin NA, Hanson GC, Bennett RM. A six-month randomized controlled trial of exercise and pyridostigmine in the treatment of fibromyalgia. Arthritis Rheum. 2008;58(2):612–22.

    CAS  Article  Google Scholar 

  48. 48.

    Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377–81.

    CAS  Article  Google Scholar 

  49. 49.

    Franco YR, Liebano RE, Moura KF, de Oliveira NT, Miyamoto GC, Santos MO, et al. Efficacy of the addition of interferential current to Pilates method in patients with low back pain: a protocol of a randomized controlled trial. BMC Musculoskelet Disord. 2014;15:420.

    Article  Google Scholar 

  50. 50.

    Muscolino JE, Cipriani S. Pilates and the “powerhouse”—I. J Bodyw Mov Ther. 2004;8(1):15–24.

    Article  Google Scholar 

  51. 51.

    Muscolino JE, Cipriani S. Pilates and the “powerhouse”—II. J Bodyw Mov Ther. 2004;8(2):122–30.

    Article  Google Scholar 

  52. 52.

    Curnow D, Cobbin D, Wyndham J, Boris Choy ST. Altered motor control, posture and the Pilates method of exercise prescription. J Bodyw Mov Ther. 2009;13(1):104–11.

    Article  Google Scholar 

  53. 53.

    Wells C, Kolt GS, Bialocerkowski A. Defining Pilates exercise: a systematic review. Complement Ther Med. 2012;20(4):253–62.

    Article  Google Scholar 

  54. 54.

    Willan AR, Briggs AH, Hoch JS. Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data. J Health Econ. 2004;13(5):461–75.

    Article  Google Scholar 

  55. 55.

    Black WC. The CE plane: a graphic representation of cost-effectiveness. Med Decis Mak. 1990;10(3):212–4.

    CAS  Article  Google Scholar 

  56. 56.

    Fenwick E, O'Brien BJ, Briggs A. Cost-effectiveness acceptability curves–facts, fallacies and frequently asked questions. J Health Econ. 2004;13(5):405–15.

    Article  Google Scholar 

  57. 57.

    Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94(2):149–58.

    CAS  Article  Google Scholar 

  58. 58.

    Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. JASA. 1958;53(282):457–81.

    Article  Google Scholar 

  59. 59.

    Klein JP, Moeschberger ML. Survival analysis: techniques for censored and truncated data. 2nd ed. New York: Springer Science & Business Media; 2003.

  60. 60.

    Rooks DS, Gautam S, Romeling M, Cross ML, Stratigakis D, Evans B, et al. Group exercise, education, and combination self-management in women with fibromyalgia: a randomized trial. Arch Intern Med. 2007;167(20):2192–200.

    Article  Google Scholar 

  61. 61.

    Franco KM, Franco YD, Oliveira NB, Miyamoto GC, Santos MO, Liebano RE, et al. Is interferential current before Pilates exercises more effective than placebo in patients with chronic nonspecific low Back pain?: a randomized controlled trial. Arch Phys Med Rehabil. 2017;98(2):320–8.

    Article  Google Scholar 

Download references


Not Applicable.


This study was funded by Sao Paulo Research Foundation - FAPESP (process number 2016/12962–0 and 2015/21590–6). FAPESP will not be involved with the data collection or analysis.

Availability of data and materials

The datasets that will be used and/or analyzed during the current study will be available from the corresponding author on reasonable request.

Author information




KFMF, GCM and CMNC developed the study. KFMF, YRSF, EMESS, BCBN and GCM will collect data. CMNC will carry out the statistical analysis. KFMF, GCM and CMNC contributed to the improvement of the paper. All authors contributed to the refinement of the study protocol and approved the final manuscript.

Corresponding author

Correspondence to Katherinne Ferro Moura Franco.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the Research Ethics Committee of Universidade Cidade de São Paulo (CAAE: 51328215.1.0000.0064). To participate in this study all participants will give consent and sign the Informed Consent Form, before baseline assessment.

Consent for publication

The subject in pictures appearing in the additional file has provided written consent to appear in the figures.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Additional file

Additional file 1:

Exercises added and altered from the previously published exercise booklet49. (DOCX 1702 kb)

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Franco, K.F.M., Franco, Y.R., Salvador, E.M.E.S. et al. Effectiveness and cost-effectiveness of the modified Pilates method versus aerobic exercise in the treatment of patients with fibromyalgia: protocol for a randomized controlled trial. BMC Rheumatol 3, 2 (2019).

Download citation


  • Pilates method
  • Aerobic exercise
  • Economic evaluation